CONMED Corp
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
CNMD$51.21-1.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits, Financial Statement Schedules
| Index to Financial Statements | ||
|---|---|---|
| Management’s Report on Internal Control Over Financial Reporting | 43 | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 238) | 44 | |
| Consolidated Balance Sheets at December 31, 2023 and 2022 | 46 | |
| Consolidated Statements of Comprehensive Income (Loss) for the Years Ended December 31, 2023, 2022 and 2021 | 47 | |
| Consolidated Statements of Shareholders’ Equity for the Years Ended December 31, 2023, 2022 and 2021 | 48 | |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2023, 2022 and 2021 | 49 | |
| Notes to Consolidated Financial Statements | 51 | |
| (2) | List of Financial Statement Schedules | |
| Valuation and Qualifying Accounts (Schedule II) for the Years Ended December 31, 2023, 2022 and 2021 | 82 | |
| All other schedules have been omitted because they are not applicable, or the required information is shown in the financial statements or notes thereto. | ||
| (3) | List of Exhibits | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.